0000899243-20-031942.txt : 20201123 0000899243-20-031942.hdr.sgml : 20201123 20201123173053 ACCESSION NUMBER: 0000899243-20-031942 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201119 FILED AS OF DATE: 20201123 DATE AS OF CHANGE: 20201123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SELLERS LISA CENTRAL INDEX KEY: 0001829669 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39725 FILM NUMBER: 201339133 MAIL ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MARAVAI LIFESCIENCES HOLDINGS, INC. CENTRAL INDEX KEY: 0001823239 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 546-0004 MAIL ADDRESS: STREET 1: 10770 WATERIDGE CIRCLE SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-19 0 0001823239 MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI 0001829669 SELLERS LISA C/O MARAVAI LIFESCIENCES HOLDINGS, INC. 10770 WATERIDGE CIRCLE, SUITE 200 SAN DIEGO CA 92121 0 1 0 0 See Remarks Employee Stock Options (Right to Buy) 27.00 2020-11-19 4 A 0 60000 0.00 A 2030-11-19 Class A Common Stock 60000 60000 D Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan in connection with the pricing of the Issuer's initial public offering. These options will vest 25% on November 19, 2021 and in equal monthly installments thereafter over the next three years, subject to the reporting person's continued employment with the Issuer. Chief Operating Officer, Protein Detection /s/ Kurt Oreshack, by power of attorney for Lisa Sellers 2020-11-23